Irish Journal of Medical Science

, Volume 183, Issue 2, pp 249–252 | Cite as

Tinzaparin safety and efficacy in pregnancy

  • A. KhalifehEmail author
  • J. Grantham
  • J. Byrne
  • K. Murphy
  • F. McAuliffe
  • B. Byrne
Original Article



Unfractionated heparin has largely been replaced by low molecular weight heparin in the treatment and prevention of thrombosis and recurrent miscarriage in pregnancy. There is little information, however, about the efficacy and safety of tinzaparin, which has the advantage of being administered as a single daily dose.


To evaluate the safety and efficacy of tinzaparin use in pregnancy.


We retrospectively reviewed the medical records of women who were prescribed tinzaparin during pregnancy and the puerperium in our hospitals from January 2000 to December 2008. Tinzaparin was given as a single daily prophylactic dose for women with a history of venous thromboembolism (VTE) or recurrent miscarriage and as a single daily therapeutic dose for women diagnosed with VTE. The primary outcomes recorded were thrombosis, bleeding, allergy and thrombocytopenia.


One hundred and forty-nine women aged between 17 and 44 years received tinzaparin in pregnancy and the puerperium over the study period. The dose administered was therapeutic in 21 (14 %) cases and prophylactic in all others. VTE recurred in three women who had a history of VTE (3.6 %). Antepartum and postpartum haemorrhage occurred in 9.7 and 5 % of cases, respectively and two women developed thrombocytopenia but their platelets remained above 100,000/ml. Fifty-seven women (38 %) had regional anaesthesia without complication.


Our study demonstrates a safety profile for tinzaparin in pregnancy that is equivalent to other low molecular weight heparins with the advantage of single daily dosing.


Tinzaparin Anticoagulation Venous thromboembolism Pregnancy 


Conflict of interest



  1. 1.
    Rosenkranz A, Hiden M, Leschnik B et al (2008) Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 99(2):331–337PubMedGoogle Scholar
  2. 2.
    Centre for Maternal and Child Enquiries (CMACE) (2011) Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 118 (Suppl 1):1–203Google Scholar
  3. 3.
    Chang J, Elam-Evans LD, Berg CJ et al. (2003) Pregnancy-related mortality surveillance-United States, 1991–1999. MMWR Surveill Summ 52(2):1–8Google Scholar
  4. 4.
    Flessa HC, Kapstrom AB, Glueck HI et al (1965) Placental transport of heparin. Am J Obstet Gynecol 93:570–573PubMedGoogle Scholar
  5. 5.
    Harenberg J, Schneider D, Heilmann L et al (1993) Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women. Haemostasis 23:314–320PubMedGoogle Scholar
  6. 6.
    Bates SM, Greer IA, Middeldorp S et al (2012) (2012) Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(Suppl 2):e691S–e736SPubMedCentralPubMedGoogle Scholar
  7. 7.
    Van Dongen CJ, van den Belt AG, Prins MH et al. (2004) Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev (4):CD001100. ReviewGoogle Scholar
  8. 8.
    Sanson BJ, Lensing AWA, Prins MH et al (1999) Safety of LMWH in pregnancy: a systematic review. ThrombHaemost 81:668–672Google Scholar
  9. 9.
    Royal College of Obstetrics and Gynaecology Green Top Guideline Number 37Google Scholar
  10. 10.
    Marik PE, Plante LA (2008) Venous thromboembolic disease and pregnancy. N Engl J Med 359(19):2025–2033PubMedCrossRefGoogle Scholar
  11. 11.
    Smith MP, Norris LA, Steer PJ et al (2004) Tinzaparin sodium for thrombosis treatment and prevention during pregnancy. Am J Obstet Gynecol 190(2):495–501PubMedCrossRefGoogle Scholar
  12. 12.
    Ní Ainle F, Wong A, Appleby N et al (2008) Efficacy and safety of once daily LMWH (Tinzaparin sodium) in high risk pregnancy. Blood Coagul Fibrinolysis 19(7):689–692PubMedCrossRefGoogle Scholar
  13. 13.
    Nelson-Piercy C, Powrie R, Borg JY et al (2011) Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile. Eur J Obstet Gynecol Reprod Biol 159(2):293–299PubMedCrossRefGoogle Scholar
  14. 14.
    Thromboprophylaxis During Pregnancy, Labour and after Vaginal Delivery. GreenTop Guideline 37Google Scholar
  15. 15.
    Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA et al (2003) Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 28:172–197PubMedGoogle Scholar
  16. 16.
    Ogden CL, Carroll MD, Kit BK et al (2012) Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA 307(5):483–490PubMedCrossRefGoogle Scholar
  17. 17.
    Hayes-Ryan D, Byrne BM (2012) Prevention of thrombosis in pregnancy: how practical are consensus derived clinical practice guidelines? J Obstet Gynaecol 32:740–742PubMedCrossRefGoogle Scholar
  18. 18.
    Greer IA, Nelson-Piercy C (2005) Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106(2):401–407PubMedCrossRefGoogle Scholar
  19. 19.
    Pabinger I, Grafenhofer H, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K et al (2002) Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood 100:1060–1062PubMedCrossRefGoogle Scholar
  20. 20.
    Donnelly J, Murphy K, McAuliffe F (2012) Obstetric outcome with low molecular weight heparin therapy during pregnancy. IMJ 105(1):27–29PubMedGoogle Scholar
  21. 21.
    Wang Peng, Xin Xiao-tang, La Hai et al (2011) Spontaneous cervical epidural hematoma during pregnancy: case report and literature review. Eur Spine J 20(Suppl 2):S176–S179PubMedCrossRefGoogle Scholar
  22. 22.
    Lutomski JE, Byrne BM, Devane D, Greene RA (2012) Increasing trends in atonic postpartum haemorrhage in Ireland: an 11 year population-based cohort study. BJOG 119:306–314PubMedCrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2013

Authors and Affiliations

  • A. Khalifeh
    • 1
    Email author
  • J. Grantham
    • 4
  • J. Byrne
    • 3
  • K. Murphy
    • 3
  • F. McAuliffe
    • 2
  • B. Byrne
    • 4
  1. 1.Lankenau Medical CenterWynnewoodUSA
  2. 2.UCD Obstetrics and Gynaecology, School of Medicine and Medical ScienceUniversity College Dublin, National Maternity HospitalDublin 2Ireland
  3. 3.National Maternity HospitalDublin 2Ireland
  4. 4.Coombe Women and Infants University HospitalDublin 8Ireland

Personalised recommendations